Stay updated on Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial

Sign up to get notified when there's something new on the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T01:38:02.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added new trial sites: Wrocław, Poland (51-685) and Lviv, Ukraine (79029), and added the collaborator 'Neurofocus LLC'. Removed outdated site entries for Wroclaw (51-685), Lviv in Chernihiv Governorate (79007), and the MNE Lviv Territorial Medical Association Clinical Hospital for Palliative Care.
    Difference
    0.3%
    Check dated 2026-03-28T13:52:34.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added Naples, Campania, Italy, 80138 as a study site and removed Napoli, Campania, Italy, 80138. Updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T08:38:26.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and the previous Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-06T19:22:05.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:40:23.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1; no visible changes to trial content or navigation in the page screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:10:11.000Z thumbnail image

Stay in the know with updates to Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page.